Elevance Health (ELV) Stock Price, Fundamentals & Analysis

What ELV does

Elevance Health (ELV) is a large US health benefits company based in Indianapolis. It operates through four segments — Health Benefits, CarelonRx, Carelon Services, and Corporate & Other — and offers health plans and services to individual, employer group, Medicare, Medicaid, and FEP members. The company also runs a pharmacy services business that includes home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, and a prescription drug database.

Key numbers explained

• $398.56 is the current share price, the amount you would pay for one share right now.
• The trailing P/E ratio of 17.6 shows how much investors pay per dollar of the company's last 12 months of earnings; a lower number can suggest the stock is cheaper relative to earnings.
• The forward P/E ratio of 13.5 uses expected future earnings, which can make the valuation look more attractive if those earnings grow.
• Earnings per share of $22.62 is the portion of the company's net income allocated to each outstanding share over the last 12 months.
• The dividend yield of 1.71% tells you the annual dividend as a percentage of the current share price; it is the cash return you receive for holding the stock.
• Market cap of $86.44B is the total value of all outstanding shares and is used to classify the company as a large-cap stock.
• Beta of 0.7 suggests the stock tends to move less than the overall market, which can mean lower volatility.
• Revenue of $201.11B and profit margin of 2.5% show the scale of the business and how much of each sales dollar remains as profit after expenses.

Recent news

Recent headlines include a discussion on the financial case for healthsharing models, a look at whether UnitedHealth signaled a fix before its stock ran, and questions about whether UNH can keep growing earnings while sales stall. Other stories cover how Centene's strong cash flow is reshaping its balance sheet, whether ELV stock may be below fair value after reaffirmed guidance, and whether CVS stock is worth buying for the margin Aetna is rebuilding.

What to watch

Elevance Health operates in the Healthcare Plans industry, which is sensitive to changes in healthcare policy, regulation, and government spending on programs like Medicare and Medicaid. Investors often compare managed care companies with peers such as Cigna (CI) and other large insurers. The company is part of the S&P 500, so broader market moves can affect its price. Earnings reports, especially the upcoming one on Oct 21, 2026, and the ex-dividend date of Sep 10, 2026, are key dates that can drive trading activity and income-focused decisions.